A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With Melanoma
Clinical trial NCT06163170 · COMPLETED
Trial details
- NCT number
- NCT06163170
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-14
- Primary completion
- 2023-09-25
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.